Company Overview

Development Stage

About the Company

江苏赛亿生物技术有限公司从事细胞治疗药物研发行业,致力于以细胞治疗为主的创新药物研发,尽早实现临床转化和商业化。
公司由生物制品领域内知名企业家和科学家联合创立,拥有丰富的干细胞药物和免疫细胞药物研发经验,公司布局了针对糖尿病足、膝骨关节炎、多发硬化症和糖尿病肾病四条药物研发管线,拥有完善的干细胞建系技术,细胞株通过了中检院质量复核检定,团队早期研发的细胞制剂已经在国内三甲医院开展了非注册临床试验。
公司地处江苏省泰州市,位于国家医药高新技术产业开发区-中国医药城(CMC)内,拥有1500m2研发实验室和GMP-like车间,涵盖了细胞株建系、规模化制备、制剂和稳定性以及质量研究等区域,硬件设施完备。
凭借优异的研发管线和出色的产品开发能力,江苏赛亿生物技术有限公司有望尽快完成细胞药物的开发和商业化,解决尚未满足的临床需求。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Recruitment Overview / Current Status (13 open positions)

Manage
Note: How fast is hiring at 江苏赛亿生物技术有限公司 growing? 2026: 15 openings (up 25%), 2025: 12 openings (down 25%), 2024: 16 openings (up 300%), 2023: 4 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 29%
  • 2024: Up 133%
Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 江苏赛亿生物技术有限公司 growing? Master's recruitment over the years: 2025: 5 openings (down 29%), 2024: 7 openings (up 133%), 2023: 3 openings.

— What Are the Salaries Like? (16 records)

Manage
salary range: 4.5K - 30K, 62.6% of roles pay ¥6-15K
Note: salary statistics are based on 16 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 江苏赛亿生物技术有限公司?62.6% of positions earn 6-15K, Undergraduate salary: ¥。Taizhou salary ranking top 30,工厂生产类 average salary ¥11.0K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Job Category

  • 工厂生产类
    50% of total 50%
  • 质量管理类
    37.5% of total 37.5%
  • 其他(研发和技术类)
    31.3% of total 31.3%
  • 生物/制药/化工/环保类
    31.3% of total 31.3%

Education

  • 大专
    31.3% of total 31.3%
  • 本科
    31.3% of total 31.3%
  • 硕士
    31.3% of total 31.3%
  • 博士
    6.3% of total 6.3%

Experience

  • 1-3年
    56.3% of total 56.3%
  • 不限
    18.8% of total 18.8%
  • 3-5年
    12.5% of total 12.5%
  • 5-10年
    12.5% of total 12.5%
View Detailed Analysis

What does 江苏赛亿生物技术有限公司 require? Who is 江苏赛亿生物技术有限公司 hiring? recruitment: 工厂生产类占比最多占50%,其次是质量管理类占37.5%. What education can get in at ? 大专占比最多占31.3%,其次是本科占31.3%. High education required at ? 硕士占31.3%,博士占6.3%. Work experience required at ? 1-3年占比最多占56.3%,其次是不限占18.8%. Where are the job locations at ? 泰州占比最多占100%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 1,567.1523万(元)
Legal Representative: 李磊
Date Established:
Credit Code: 91321291MACMQT8J6C
Registered Address: 江苏省泰州市医药高新技术产业开发区药城大道一号(创业路东侧、园南路北侧)新药创制基地二期C幢大楼501-513室

People who follow this company also follow

Competitors (Similar Companies)

劳务派遣 管理咨询 企业管理 咨询
生物科技/生物工程 试剂 分子生物学 细胞培养
CRO 临床研究 生物医疗 新药研发
生物科技/生物工程 高通量测序 单细胞测序 腺苷
工程材料 建筑 建筑规划 实验室设计
“A professional green energy storage integrated service provider in the”
压力管道安装 管道安装 压力管道 特种设备
环境监测 环境工程 环境检测 检测
生物实验 干细胞 细胞技术服务 肿瘤治疗
“Promoting human health”
生物科技/生物工程 细胞治疗 细胞培养 细胞培养基
V
“一家生物医药研发及生产服务型平台企业”
“A high-tech biotechnology enterprise dedicated to the research and dev”
半导体 生产 制造 掩膜版
生物科技/生物工程 新药筛选 再生医学 大健康

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates